US70465T1079
US70465T1079
PDS Biotechnology Corporation
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | -- | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 31.543.959 | 36.321.195 | 13.2% | |
| Operating Income | -31.543.959 | -36.321.195 | 13.2% |
| Pretax Income | -35.665.325 | -38.479.553 | 7.3% |
| Net Income Common Stockholders | -34.495.505 | -37.610.384 | 8.3% |
| -- | -- | -- | |
| -- | -- | -- |